Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease

BACKGROUND: Inflammatory bowel disease (IBD) is a chronic relapsing-remitting disease. An adverse immune reaction toward the intestinal microbiota is involved in the pathophysiology and microbial perturbations are associated with IBD in general and with flares specifically. Although medical drugs ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Becker, Heike E. F., Demers, Karlijn, Derijks, Luc J. J., Jonkers, Daisy M. A. E., Penders, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996055/
https://www.ncbi.nlm.nih.gov/pubmed/36910207
http://dx.doi.org/10.3389/fmicb.2023.1107976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996055/
https://www.ncbi.nlm.nih.gov/pubmed/36910207
http://dx.doi.org/10.3389/fmicb.2023.1107976

Ejemplares similares